Suresh K Kalangi
Suresh K Kalangi
Unknown affiliation
No verified email
TitleCited byYear
Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications
M Gokara, T Malavath, SK Kalangi, P Reddana, R Subramanyam
Journal of Biomolecular Structure and Dynamics 32 (8), 1290-1302, 2014
Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits
T Chandramohan Reddy, P Aparoy, N Kishore Babu, K Anil Kumar, ...
Protein and peptide letters 17 (10), 1251-1257, 2010
Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper (II), nickel (II) and palladium (II) complexes
M Jagadeesh, M Lavanya, SK Kalangi, Y Sarala, C Ramachandraiah, ...
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 135, 180-184, 2015
Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors
P Aparoy, KK Reddy, SK Kalangi, TC Reddy, P Reddanna
Bioorganic & medicinal chemistry letters 20 (3), 1013-1018, 2010
Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine
SK Kalangi, A Dayakar, D Gangappa, R Sathyavathi, RS Maurya, DN Rao
Experimental parasitology 170, 184-192, 2016
Halo-substituted thiosemicarbazones and their copper (II), nickel (II) complexes: Detailed spectroscopic characterization and study of antitumour activity against HepG2 human …
M Jagadeesh, SK Kalangi, LS Krishna, AV Reddy
Spectrochimica Acta Part A: molecular and biomolecular spectroscopy 118, 552-556, 2014
Bioimaging of 5 fluorouracil conjugated to CdTe quantum dots in MCF-7 breast cancer cells
SK Kalangi, R Sathyavathi, DN Rao, R Pallu
Journal of Bionanoscience 6 (1), 17-22, 2012
Emergence of leptin in infection and immunity: Scope and challenges in vaccines formulation
D Alti, C Sambamurthy, SK Kalangi
Frontiers in cellular and infection microbiology 8, 2018
Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model
PR Suresh K. Kalangi,Nitin K. Swarnakar, R. Sathyavathi, D. Narayana Rao ...
Oxidative Medicine and Cellular Longevity, 2018
Quantum dot–based molecular imaging for the detection of inflammation and cancer in mice
RP Suresh. Kalangi, N.K. Swarnakar, R. Sathyavathi, S. Jain, D.N. Rao
J Nucl Med 54 (no. Supplement 1), 3A-35, 2013
Synthesis, characterization and bio-distribution of Quantum dot-celecoxib conjugates in mouse paw edema model.
R Pallu
The system can't perform the operation now. Try again later.
Articles 1–11